본문 바로가기
bar_progress

Text Size

Close

[eDisclosure Notice] KOSDAQ - 17th

[Asia Economy Reporter Lee Seon-ae]



▲Pangen=Approved by the Ministry of Food and Drug Safety for changes in the multinational Phase 3 clinical trial plan of the hemophilia treatment drug ‘PGA40’


▲Genie Music=Major shareholder changing from KT Studio Genie to KT Season


▲Dragonfly=Decision to acquire 7.4 billion KRW worth of shares in Rinofec


▲Daeyu=Decision to acquire 43 billion KRW worth of shares in Andyforce


▲YTN=CEO changed from Jeong Chan-hyeong to Woo Jang-gyun


▲Wider Planet=Decision to acquire 8.6 billion KRW worth of shares in IBL


▲iTox=Delisting resolution by the Korea Exchange KOSDAQ Market Committee


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top